HAPLN1 and prostate cancer: The pro-tumorigenic role of VCAN/HAPLN1 complex has been tested in several other tumor types, such as malignant pleural mesothelioma [63] and breast and prostate cancers and increased tumor-specific VCAN expression levels have been reported in ACC and several other tumor types [64-69].